We had previously identified astrocytosis as an important component of the AD-associated molecular changes in our mouse models (Additional File 1: Fig. S6) and, interestingly, Gfap was one of the genes whose expression was partially downregulated in response to penbutolol (Additional File 1: Fig. S10d). This evidence concerns the gene GFAP and Alzheimer disease.